PMMI research shows pharmaceutical manufacturers face a growing market and will need OEMs and suppliers to overcome ...

"Breakthrough new drugs such as specialized oncology treatments as well as new applications for existing drugs — like GLP-1 ...

Merck's affordable Ebola vaccine initiatives, Abbott's profit challenges, U.S. vaccination policy changes under Health ...

Staying ahead of pharma supply challenges rests on anticipatory pillars and does not require reinventing the wheel, says ...

Explore key identity management challenges in pharma and biotech SaaS platforms and learn practical solutions for security, ...

While the threat of U.S. import tariffs prompted a surge in drug production last year, that output is slated to slow across multiple geographies in 2026. | While the threat of U.S. import tariffs ...

Pharma's investment in the digital health space is getting more and more real and substantive as companies move beyond the pilot stage and start to launch real digital health interventions, from Teva ...

For biotech companies the past two years have been challenging. Biotech investments have not reached the record levels of ...

Cantor Fitzgerald writes that the Skytrofa update probably overshadowed another key update from the call. Achieving breakeven this year is unlikely unless the company significantly reduces costs, ...

Pharmaceutical Cliff Diving is a consultancy-style report which identifies, assesses, and provides insights on the key challenges that industry is experiencing now and in the near future. Through CBR ...

As more and more partnerships between digital therapeutics and pharma companies begin to emerge, the two industries have started to size each other up. While this may foster an exchange of ideas, ...

Tuesday, Ascendis Pharma A/S (NASDAQ:ASND) reported second-quarter sales of $38.76 million (35.9 million euros), missing the consensus of $92.7 million, down from 47.4 million euros reported a year ...